Skip to content

Hospital-level Variation in the Management of Blood Pressure and Low-density Lipoprotein in the Outpatient Hypertensives in China-a Cross Sectional Study

Survey on BP, Lipids and Cardiovascular Risks in the Outpatient Hypertensives and Continuing Medical Education Program

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03862183
Enrollment
21000
Registered
2019-03-05
Start date
2017-07-01
Completion date
2020-12-30
Last updated
2019-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia, Hypertension

Brief summary

To investigate the proportion, medication use and control rate of metabolic abnormalities such as dyslipidemia in outpatients with hypertension in different levels of hospitals in China. To investigate the gap between guidelines and clinical practices, and analyze the cause. we also set up a continuing medical education program to narrow the gap and the effect of the program will be estimated.

Interventions

OTHERcontinuing medical education program

educating all the involved doctor the same medical knowledge on hypertension control

Sponsors

Huashan Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Outpatients from departments of Cardiology, Endocrinology, Nephrology, Neurology, Geriatrics or General Internal Medicine. 2. Diagnosed as hypertension. Diagnostic criteria: 1)The office BP measured at the day of visit and at least one time before that day were above the cut-off values ( ≥140 mmHg SBP and/or ≥90 mmHg DBP); 2)for patients with normal BP at the day of visit, they should have already been given pre-treatment with antihypertensive drugs ≥ 2 weeks. 3. Voluntary participation.

Exclusion criteria

1. Patients aged\< 18 years old. 2. Patients without a definite diagnosis of hypertension(for instance, if the patient has been taking antihypertensive drugs irregularly, it is difficult to confirm the diagnosis of hypertension). 3. Patients with a definite diagnosis of secondary hypertension. 4. Patients are diagnosed dyslipidemia with clear cause, such as nephrotic syndrome, severe hypothyroidism, terminal stage of malignancy, etc. 5. Patients are diagnosed end-stage renal disease, hemodialysis, and peritoneal dialysis patients. 6. Patients diagnosed with mental abnormalities who are unable to complete the questionnaire. 7. Patients have once participated in this research during this study cycle(to avoid repeated participation).

Design outcomes

Primary

MeasureTime frameDescription
rate of blood pressure goal achievement2017-2020systolic blood pressure\<140mmHg and diastolic blood pressure\<90mmHg

Countries

China

Contacts

Primary Contactxiufang gao, PhD
sophiakao@126.com+86 13788908071

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026